Berberine C9-Derivatives Selective Cytotoxicity Depends on Balance Between Mitochondrial Damage and DNA Intercalation
- PMID: 41668448
- DOI: 10.1002/ardp.70199
Berberine C9-Derivatives Selective Cytotoxicity Depends on Balance Between Mitochondrial Damage and DNA Intercalation
Abstract
Berberine, a naturally occurring compound, inhibits the growth of cancer cells in vitro at micromolar concentrations. Selective cytotoxicity was revealed for berberine derivatives and monoterpene aminoalcohols in the FCCT (fluorescent cells co-cultivation test) screening of almost a 100 recently synthesized compounds. C9-substituted berberines were found to be selective and cytotoxic in the nanomolar concentration range, and were investigated in detail. They exhibit some selectivity for A549 and MCF7 cancer cells in comparison to non-cancerous VA13 cells. Several berberine derivatives were synthesized, which allowed us to analyze their structure-activity relationships (SAR) and mechanism of action on the cells. Investigation of berberine's and its derivatives' action on the cells revealed some similarities with DNA intercalators. Compounds bearing charged groups, such as 1 and 2, have also been observed to disrupt the mitochondrial membrane potential. Compound 17a, lacking a charge on the nitrogen, retains the effects on the cells and the ability to intercalate DNA, but affects mitochondria only at high concentrations. The significant mechanism of action of the investigated berberine derivatives is intercalation into DNA.
Keywords: berberine derivatives; cytotoxicity; intercalation; mechanism of action; selectivity.
© 2026 Deutsche Pharmazeutische Gesellschaft.
References
-
- C. A. Dehelean, I. Marcovici, C. Soica, et al., “Plant‐Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy,” Molecules 26 (2021): 1109.
-
- D. J. Newman and G. M. Cragg, “Natural Products as Sources of New Drugs over the Last 25 Years,” Journal of Natural Products 70 (2007): 461–477.
-
- R.‐G. Xiong, S.‐Y. Huang, S.‐X. Wu, et al., “Anticancer Effects and Mechanisms of Berberine From Medicinal Herbs: An Update Review,” Molecules 27 (2022): 4523, https://doi.org/10.3390/molecules27144523.
-
- J.‐W. Shou and P.‐C. Shaw, “Therapeutic Efficacies of Berberine Against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms,” Cells 11 (2022): 796, https://doi.org/10.3390/cells11050796.
-
- J. Li, J. Li, J. Ni, et al., “Berberine Relieves Metabolic Syndrome in Mice by Inhibiting Liver Inflammation Caused by a High‐Fat Diet and Potential Association With Gut Microbiota,” Frontiers in Microbiology 12 (2022): 752512.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
